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ABSTRACT  
BACKGROUND  
Epidemiological studies have shown that the risk for periodontitis in diabetes 
mellitus patient is greater than non diabetics. Diabetes mellitus is now documented to 
significantly enhance susceptibility to severe periodontitis. Increased susceptibility to 
periodontitis has been associated with impaired neutrophil function in diabetes mellitus. 
The objectives of this study are to compare the neutrophil function in diabetic and non 
diabetic patients with generalized chronic periodontitis and in generalized aggressive 
periodontitis patients and to compare this study in control group. 
AIM 
          To assess neutrophil function i.e. Chemotaxis, Phagocytosis and Specific Granule 
Release in Diabetic and Non Diabetic patients with Generalized Chronic Periodontitis 
and Generalized Aggressive Periodontitis in Indian population. 
Materials and Method: 
60 patients were selected to participate in the study which was divided into four groups. 
These patients were selected according to clinical and radiographic criteria. Blood 
samples from 60 patients were collected after drawing 5ml peripheral venous blood and 
then various assays were carried out to assess the neutrophil functions mentioned above. 
Statistical analysis of the results was done using ANOVA followed by Tukey HSD test. 
Results:           
 It was found that defective chemotaxis present in diabetic and in generalized 
aggressive periodontitis patients. Defective phagocytosis was observed in diabetic, 
generalized chronic, and in generalized aggressive periodontitis patients. And defective  
specific granule release assay was observed only in diabetic patient when compared to 
healthy control. 
Conclusion:  
            This study has proved that there is association between neutrophil dysfunction 
and severity of periodontal diseases. Hence, further longitudinal and clinical trials with 
larger sample size and newer sensitive techniques are needed. 
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                                          INTRODUCTION 
      Diabetes mellitus is a multifactorial disease. The disease is characterized by 
hyperglycemia, hyperlipidemia, and associated complication.
10, 18
 Diabetes mellitus 
represents one of the major chronic health problem facing the world today.  Diabetes 
mellitus develops from either defect in insulin production or an impaired utilization of 
insulin. Based upon these two conditions diabetes mellitus can be divided into two main 
types. Type I (IDDM) or juvenile diabetes caused by destruction of pancreatic islets cells. 
Type II (NIDDM) or adult onset diabetes which results from the defect in the insulin 
molecule or alter cell receptors for insulin and represents impaired insulin function rather 
than the deficiency. Periodontal disease is an infectious inflammatory process of 
multifactorial origin that involves the interplay between bacteria, host and environmental 
factors.
47
 The dynamics between the host immune responses and oral bacteria is essential 
to understand the pathogenesis of periodontal diseases.
26 
      Although numerous host defense mechanisms are called into an action by the 
bacterial invasion at the gingival sulcus, substantial evidence indicates that the 
Polymorphonuclear Neutrophils (PMNs) are the key cellular elements of the innate 
immune system, providing protection from invading bacteria.
48
 Neutrophils impairment 
leads to increased susceptibility to Periodontitis in diabetic patient. Epidemiologic studies 
have shown that the risk for Periodontitis in diabetes mellitus patient is greater than non 
diabetic. Type I and II diabetes are significantly enhances susceptibility to severe 
Periodontitis. In Aggressive Periodontitis there is decreased responsiveness of PMN to 
chemotactic stimuli.
65 
It has been demonstrated that their serum is shown to be a poor 
source of chemotactic factor.
65
  The important role of PMNs play in optimal functioning 
of the immune defense system, has led to speculation that a partly compromised system 
could severely weaken the defense mounted against a bacterial insult and permit the 
occurrence and progression of infections.
23
 Since there are few studies which have been 
done in this context and very little data available in Indian population, the present study 
was undertaken to assess the invitro  neutrophils chemotaxis, phagocytosis and specific 
granule release in diabetic and non diabetic patient with Generalized Chronic 
Periodontitis and in Generalized Aggressive Periodontitis patient.   
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 AIM 
The study was aimed to assess neutrophils function i.e. Chemotaxis, Phagocytosis and 
Specific Granule Release in Diabetic and Non Diabetic patients with Generalized 
Chronic Periodontitis and Generalized Aggressive Periodontitis in Indian population. 
 
 
OBJECTIVES 
1. To assess Chemotactic activity of neutrophils in Diabetic and Non Diabetic patients 
with Generalized Chronic Periodontitis and in Generalized Aggressive Periodontitis 
(GAgP) subjects. 
2. To assess Phagocytic activity of neutrophils in Diabetic and Non Diabetic patients 
with Generalized Chronic Periodontitis and in Generalized Aggressive Periodontitis 
(GAgP) subjects. 
3. To assess Specific Granule Release activity in Diabetic and Non Diabetic patients 
with Generalized Chronic Periodontitis and in Generalized Aggressive Periodontitis 
(GAgP) subjects. 
4. To compare these neutrophil functions within the above forms of Periodontitis with 
the control group of periodontally healthy subject.   
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REVIEW OF LITERATURE 
 DIABETES MELLITUS 
       Diabetes mellitus is a clinically and genetically heterogenous group of metabolic 
disorders manifested by abnormally high levels of glucose in the blood. The 
hyperglycemia is the result of a deficiency of insulin secretion caused by pancreatic beta 
cell destruction or of resistance to the action of insulin in liver and muscle or a 
combination of these. The current classification of diabetes is based upon the 
pathophysiology of each form of disease.
11 
      Type 1 diabetes is one of the most frequent chronic childhood diseases. According to 
the American Diabetes Association, this form is present in the 5 -10% of patients with 
diabetes which is caused due to the pancreatic beta cell destruction as a result no insulin 
is produced.
11 
      Type2 diabetes is the most common form of the disease. It has a stronger genetic 
component than type 1. It occurs because of a decreased responsiveness to insulin at the 
target organs. It typically begins at around middle age (40 years) and may be treated by 
dietary modification, oral hypoglycemic agents or may require insulin in uncontrolled 
cases. Patients with long standing diabetes frequently experience pathologic changes in 
many tissues and organs and the extent of diabetic complications is related to the degree 
of metabolic control.
10, 18 
 
 
 
 
DIAGNOSTIC CRITERIA FOR DIABETES MELLITUS 
11 
      1. Classical symptoms includes polyuria, polyphagia and polydipsia 
      2. Fasting plasma glucose level ≥126mg/dl (≥7.o m mol|L) 
      3. Random or 2 hour post glucose loading venous plasma  
            Glucose level of ≥ 200mg/dl (≥11.1 m mol\L). 
 
INFLAMMATION AND DIABETES MELLITUS 
11 
      Inflammation is significantly pronounced in the presence of diabetes mellitus. 
Diabetics have impaired immune defense mechanisms which are more susceptible to 
infection and infections in diabetics are more severe when compared to non-diabetics. A 
bacterial infection decreases the effectiveness of insulin receptors on target tissue cells 
which reduces the ability of the body to utilize glucose. Poor metabolic control of 
diabetes results with a consequent increased risk of developing diabetic complications. 
DIABETES – PERIODONTITIS – INTERRELATIONSHP 11 
      The association between diabetes mellitus and Periodontitis has been the subject of 
much research and debate, with a myriad of research reports having produced conflicting 
results. Recent data suggests that Periodontitis may cause changes in systemic 
physiology. The inter relationship between Periodontitis and diabetes provides an 
example of systemic disease predisposing to oral infection and once that infection is 
established, the oral infection exacerbates the systemic disease. Both types of diabetes are 
risk factors for Periodontitis.
 
Joseph J Zambon et al (1988) 
31
 demonstrated that the sub gingival micro flora and 
serum antibody response was examined in Periodontitis patients with NIDDM. The 
predominant cultivable micro flora was determined for sub gingival plaque sampled from 
two deep periodontal pockets in each of 8 adult Periodontitis patients with NIDDM. Sub 
gingival plaque samples examined, demonstrated a high prevalence of black-pigmented 
bacteriods and suggested that the proportion of B. gingivalis (P. gingivalis) but not B. 
intermedia ( P.intermedia ) was higher in NIDDM with Periodontitis than in other groups. 
Hugoson A et al (1989) 
29 
found that the prevalence and severity of periodontal disease 
in age and sex matched adults with long and short duration insulin dependent diabetics 
and non- diabetics were compared. The study involved 82 subjects with long duration and 
72 short duration diabetics and 77 non-diabetics, all aged 20-70 years. Diabetics, 
irrespective of the duration of the disease, had a higher prevalence of sites with gingivitis 
than non-diabetics. Overall, there were no significant differences between the groups 
regarding the prevalence of tooth surfaces with probing pocket depths of 4 and 5mm. 
However, on comparison between age subgroups, long duration diabetics younger than 
45 years had significantly more 4 and 5 mm pockets than non diabetics.  
De Pommereau V et al (1992) 
20 
evaluated the periodontal status of 85, 12-18 year old 
French adolescents with IDDM and 38 healthy controls in the same age groups. Diabetic 
children had significantly more gingival inflammation than children without diabetes, in 
spite of similar plaque scores. 
Erhan Firatli (1997) 
22
 compared the periodontal status of 44 insulin dependent diabetic 
children and adolescents and 20 healthy control subjects for a period of approximately 5 
years. The differences is evaluated. The only statistically significant difference observed 
in the diabetic group was clinical attachment loss which was higher, compared to the 
controls and statistically significant. They concluded that diabetes modifies the clinical 
status of the periodontal tissues and increases the clinical attachment loss. 
Rylander H et al (1997) 
51 
concluded in their studies that there were no significant 
correlations between the periodontal variables and the duration of diabetics or insulin 
dosage. 
Paul A Moore et a1 (1999) 
50 
shows in a group of 320 adult dentate subjects (type I DM 
mean age 32.1) received a periodontal examination as part of the comprehensive oral 
health assessment Attachment loss was significantly greater for older patients whereas 
bleeding on probing and calculus levels were relatively constant across age categories 
PERIODONTITIS 
       Periodontitis is an inflammatory disease that results in destruction and degradation of 
the soft and mineralized connective tissues that supports and houses the dentition. It is 
widely accepted that initiation and progression of periodontal disease are caused by the 
presence of pathogenic micro-organisms that invade the host. These microorganisms can 
cause direct damage to the periodontium, and they can also cause damage indirectly by 
inactivating a variety of host mediated pathways that result in connective tissue 
destruction.
2 
       Neutrophils (Polymorphonuclear leucocytes [PMNs]) are critical components of the 
innate immune system and help to maintain oral health in the face of constant oral 
bacterial challenge. PMNs are the first line of defence against a microbial challenge to 
the periodontium and serve a protective function through their ability to phagocytose and 
kill microorganisms. However, along with protecting the periodontium from microbial 
invasion, PMNs release potent lysosomal enzymes and oxygen radicals that can be 
destructive to the periodontal tissues.
2 
      The vital role that PMNs play in protecting and maintaining the periodontium is 
evident in the oral manifestations present in patients with known qualitative and/or 
quantitative neutrophils disorders, such as benign neutropenia, Leukocyte Adhesion 
Deficiency type 1, and agranulocytosis. Although these diseases may have different 
clinical presentations and aetiologies, they are all associated with varying degrees of 
susceptibility to infection that manifest orally as severe Aggressive Periodontitis and the 
premature loss of primary and permanent dentition.
2 
      Till now there have been several classifications proposed and none of them stood the 
test of time, because of their dependence on clinical presentation of disease alone. In 
1999, the international workshop of a classification of periodontal diseases and 
conditions agreed upon new classification of aggressive periodontitis.
13 
AGGRESSIVE PERIODONTITIS is classified into  
      1. Localized  
      2. Generalized 
 
PRIMARY features of AGGRESSIVE PERIODONTITIS are (Lang et al 1999) 
      1. Non-contributory medical history 
      2. Rapid attachment loss and bone destruction 
      3. Familial aggregation 
 SECONDARY features of AGGRESSIVE PERIODONTITIS are 
1. Amount of microbial deposits inconsistent with the severity of periodontal 
destruction. 
2. Elevated proportions of Aggregatibacter Actinomycetemcomitans and 
Porphyromonas Gingivalis 
3. Phagocyte abnormalities 
4. Hyper-responsive macrophage phenotype, including elevated production of PGE2 
and IL-1ß in response to bacterial endotoxin. 
5. Progression of attachment loss and bone loss may be self arresting 
 
Features for Localized and Generalized Forms of Aggressive Periodontitis Are 
 LOCALIZED AGGRESSIVE PERIODONTITIS 
3, 13 
      1. Circumpubertal onset. 
      2. Localized first molar/ incisor presentation with interproximal attachment loss on at 
          least two permanent teeth one of which is a first molar and involving no more than 
          two other than first molars and incisors. 
      3. Poor serum antibody response to infecting agents. 
 
 
GENERALIZED AGGRESSIVE PERIODONTITIS 
3, 13 
      1. Usually affecting persons under 30yrs of age, but patient may be older. 
      2. Generalized interproximal attachment loss affecting at least three permanent teeth 
          other than first molars and incisors. 
      3. Pronounced episodic nature of the destruction of attachment loss and alveolar bone. 
      4. Poor serum antibody response to infecting agents. 
MICROBIAL ETIOLOGY OF AGGRESSIVE PERIODONTITIS 
54 
LOCALIZED AGGRESSIVE PERIODONTITIS 
      The most notorious relationship between specific bacterial infection and any 
periodontal disease is that between Aggregatibacter Actinomycetemcomitans and 
localized Aggressive Periodontitis. 
1. Aggregatibacter Actinomycetemcomitans displays a number of virulent factors that 
would support its capacity to induce or propagate Aggressive Periodontitis. 
2. Serological data indicates that the aggressive periodontitis patients can have very high 
antibody titers against Aggregatibacter Actinomycetemcomitans, indicating that they 
have been infected with the bacteria. As a group, Aggressive Periodontitis patients with 
such high antibody titers against Aggregatibacter Actinomycetemcomitans (and 
Porphyromonas Gingivalis) have less severe and extensive disease than do those who 
lack these antibodies. 
 
3. A limited number of studies of treatment of localized Aggressive Periodontitis have 
shown that elimination of detectable levels of A.A. through modalities including scaling, 
root planning, surgery and antibiotic treatment resulted in cessation of attachment loss as 
well as diminution of antibody response. 
4. A. Actinomycetemcomitans has been detected within diseased periodontal tissues in 
affected sites in localized aggressive periodontitis patients. Furthermore, the invasive 
properties of A. Actinomycetemcomitans can be demonstrated in invitro. Thus the data 
indicates that A. Actinomycetemcomitans is an important pathogen in localized 
aggressive periodontitis and likely to be responsible for a large percentage of associated 
lesions. 
GENERALIZED AGGRESSIVE PERIODONTITIS 
      The bacteriology of Generalized Aggressive Periodontitis appears to be somewhat 
more complex than that of localized form. This may be due to the fact that the 
populations are more heterogeneous and thus could represent subpopulation with 
different aetiologies. The bacteria that are apparently the most representative of this 
group include Porphyromonas gingivalis and Aggregatibacter Actinomycetemcomitans 
as well as Prevotella Intermedia, Bacteriodes Forsythus, Eubacterium species, 
Fusobacterium Nucleatum, Campylobacter Rectus and  number of spirochetes. Each is 
emphasized here because of its documented presence in the disease, induction of immune 
responses in human and virulent factors. 
       PMNs constitute one of the body’s primary defences against invading bacteria or 
foreign entities. Drawn towards the latter by increasing gradients of the chemoattaractants 
that the organisms generate the neutrophils task, once they reach them, to phagocytose 
and destroy the organisms. Their bactericidal functions lie in the contents of their 
granules, plasma membrane and cytoplasmic contents allows them to generate in or inject 
into the phagosome enclosing the organism. 
       The roles of chemoattractant and phagocytizable entities are very different and their 
effect on the neutrophils proceeds through different receptors and receptor mediated 
processes. 
       Neutrophils migrate to the sites of bacterial ingress or tissue damage through the 
process of chemotaxis. The term chemotaxis was introduced in 1884 by Pfeiffer, who 
described it as directional migration of leukocytes along a chemical gradient.
23 
PMN 
chemotaxis can be stimulated by various N- Formylated peptides such as FMLP. These 
small peptides are of importance since they are thought to be structural analogs of 
bacterial products, and mimic the effect of these bacterial products on human PMN.
21 
Other chemoattractants include C5a, a product of the complement cascade, products of 
phospholipids metabolism (leukotriene B4), and chemokines such as IL-8. The 
chemotactic response is initiated by the binding of the chemoattractant to specific PMN 
plasma membrane or to its cell surface receptor. This binding of chemoattaractants causes 
activation of the cytoskeletal machinery which in turn causes an array of cellular 
responses, including release of arachidonic acid and lysosomal enzymes and superoxide 
production as well as locomotion.
23 
      Neutrophils chemotaxis is the first step of host defense and plays an important role in 
the host defence against bacterial infection. N-FMLP can elicit neutrophils chemotaxis to 
the inflammatory site.
32
 The Nitro Blue Tetrazolium (NBT) test measures the respiratory 
burst activity in PMN’s   by the reduction of NBT to formazan by the superoxide anion 
generated in the burst. It is an indicator of the degree of activity in the enzyme systems 
which are usually triggered by phagocytosis and which ultimately lead to bacterial 
killing. NBT tests have been described for peripheral blood PMN's however, healthy 
control values (unstimulated cells) always fall between 0-15% positive despite attention 
to technical   detail.
52 
Clark, Page et al (1977)
 14 
evaluated the neutrophils chemotaxis in 9 patients with 
juvenile Periodontitis, 4 with normal subjects and 5 patients with the adult form of 
periodontitis as controls. Defective chemotactic responses were observed in Neutrophils 
from seven of nine juvenile patients, and a reduced level of complement-derived 
chemotactic activity was demonstrated in serum from four patients. These determinations 
were normal in all the patients with adult Periodontitis. 
 Cianciola LJ, Van Dyke TE et al. (1980) 
62 
Studied Polymorphonuclear leukocyte 
(PMNL) chemotaxis of 32 patients with localized juvenile Periodontitis (LJP), 10 adult 
patients with a history of LJP (post-LJP), 8 patients with Generalized juvenile 
Periodontitis (GJP), and 23 adults with moderate to severe Periodontitis. Based upon 
statistical analysis of chemotaxis assays, most carried out on at least two and often three 
or more separate occasions, 26 of 32 LJP patients, 7 of 10 post-LJP patients, and 5 of 8 
GJP patients exhibited cellular defects of chemotaxis, whereas only 2 of 23 of the 
patients with adult Periodontitis exhibited depressed chemotaxis. Elevated PMN 
chemotaxis was occasionally found in subjects with juvenile Periodontitis (2 of 32 with 
LJP and two of eight with GJP); however, it was found in a significant number (10 of 23) 
of patients with adult Periodontitis. The results indicate that the PMNL chemotaxis defect 
observed in juvenile Periodontitis is due to a cell-associated defect of long duration. 
Van Dyke TE, Levine MJ et al. (1983) 
63 
studied the binding of the chemotactic 
complement fragment, C5a, to peripheral blood neutrophils of Localized Juvenile 
Periodontitis (LJP) patients and normal controls which was quantitated using iodinated 
human C5a and a rapid centrifugation assay. They observed a significant reduction in the 
number of binding sites per cell on neutrophils from the patient group, whereas the 
binding affinity remained the same as control values. 
Suzuki, Neumann et al. (1983)
 56
 examined peripheral blood neutrophils from 29 LJP, 
24 GJP and 24 healthy subjects and assessed for chemotaxis, phagocytosis and spore 
germination. Chemotaxis assay was performed using Boyden diffusion chamber using 
10-8 M N-FMLP as chemoattractant and found that 23 of 29 LJP and 14 of 25 GJP 
subjects had a neutrophils defect. 
Phagocytosis assays were performed in vitro using radiolabel bacterial spores Bacillus 
cereus. 18 of 29 LJP and 7 of 24 GJP had a phagocytic defect. Neutrophils induced spore 
germination assessed in vitro showed that 13 of 20 LJP and 3 of 8 GJP had this defect. 
Ellegaard Borregaard et al. (1984) 
8
 Performed quantitative studies on phagocytosis on 
peripheral blood neutrophils isolated from 12 young and 10 adult patients with advanced 
Periodontitis. Chemotaxis was significantly reduced only in the young patients whereas 
no difference could be demonstrated between young and adult patients or controls in 
uptake of opsonised zymosan particles, in the concentration and consumption rate of 
ATP, in the rate of oxygen consumption and oxygen liberation and lysozyme during 
phagocytosis. 
Page RC, Altman LC et al. (1985) 
48
 examined cell motility of PMNs and MNs from 27 
patients with rapidly progressive Periodontitis, 5 patients with juvenile Periodontitis, and 
37 normal control subjects by using a micro chamber technique and the synthetic peptide 
N-formyl-methionyl-leucyl-phenylalanine (FMLP) as the chemoattractant. As a group, 
PMNs and MNs from patients with rapidly progressive Periodontitis manifested 
significantly enhanced random migration relative to control cell suppressed directed 
migration (chemotaxis) at FMLP doses of 10(-9) and 10(-8) M and enhanced directed 
migration at a dose of 10(-6) M FMLP. In contrast, PMNs from patients with juvenile 
periodontitis exhibited normal random migration, and directed migration was 
significantly suppressed at all doses of FMLP tested. An abnormality of either PMN or 
MN motility was observed in 26 of 27 patients with rapidly progressive Periodontitis. 
Enhanced random migration was seen in PMNs in 63%, MNs in 39%, and both cell types 
in 26% of the patients. Suppressed chemotaxis was seen in PMNs in 85%, in MNs in 
74%, and in both cell types in 69% of the patients. Thus, most, if not all, of this subgroup 
of patients with early onset, highly destructive Periodontitis have abnormalities in PMN 
or MN motility, and these defects may differ from those seen in cells from patients with 
the juvenile form of the disease. 
S. Singh, Golub et al. (1985) 
57 
developed an in vivo assay to monitor the crevicular 
leucocyte response to chemotactic agents, e.g., casein and N-formyl peptides. They 
included a control group with little or no gingival disease (C group), gingivitis (G group), 
chronic periodontitis (CP group) and Localized Juvenile Periodontitis (LJP group). 
Casein (2mg/ml) was placed into an isolated gingival crevice of each subject with a 
calibrated wire loop and the time was recorded (t=0). Leucocytes were counted in 
crevicular washes 15 minutes later and every 5 minutes thereafter up to t=50 minutes. 
This protocol was repeated for the crevice of an adjacent tooth except that the crevicular 
fluid response to the chemotactic challenge was monitored. The C,G,CP group showed a 
similar pattern of response to the chemoattractant with a single “peak” of leucocytes at 
approximately t=25 minutes. LJPs showed an abnormal pattern with two leukocytes 
peaks, one at approximately 25 minutes and the other at 45 minutes. 
Taufiq A, Offenbacher S, Van Dyke TE. (1986) 
64 
evaluated chemotaxis, phagocytosis, 
specific granule release and superoxide production in a group of 23 previously unreported 
LJP patients. Both granule release and superoxide production were found to be normal in 
chemo tactically defective LJP patients. 
Cogen, Roseman et al. (1986) 
53 
compared 13 LJP, 5 GJP patients and their matched 
controls with respect to selected leukocyte functions and indicated that there were 
significant decreases in the phagocytic and chemotactic abilities of PMN in both LJP and 
GJP. All JP patients displayed intrinsic cell defects in chemotaxis compared with controls 
and some patients displayed multiple defects including those which were serum 
associated. 
Page, Beaty et al. (1987) 
49
 observed that both neutrophils and monocytes from patients 
with generalized prepubertal periodontitis do not adhere to surfaces normally, and this 
defect is thought to be responsible for the observed abnormality in chemotaxis. 
Kinane DF. Cullen. (1989) 
33
 The locomotory behaviour of peripheral blood neutrophils 
(PMNs) from patients with juvenile (JP) and rapidly progressive (RPP) forms of early-
onset periodontal disease was studied under agarose technique and formyl methionyl-
phenylalanine (FMLP) as the chemoattractant. PMNs from experimental patients showed 
normal random, chemotactic and chemokinetic locomotory behaviour when compared 
with control subjects. Further investigation of single-cell movements using time-lapse 
video analysis also failed to show any significant differences in locomotory behaviour 
between the PMNs of experimental and control individuals. They concluded that the 
differences in technique may account for much of the variation which exists in the 
literature with respect to PMN locomotion in periodontal disease. In the final analysis, it 
is difficult to dispute direct observation of moving cells and using this approach, they 
have been unable to confirm the presence of any PMN locomotory defect in their series 
of patients with early-onset periodontal disease. 
Heikki Repo, Saxen et al. (1990) 
27
 studied the chemotaxis of peripheral blood 
polymorphonuclear leukocytes (PMNs) and monocyets and the production of tumour 
necrosis factor alpha by monocytes of patients with juvenile Periodontitis (JP). As a 
group, the patients' PMNs showed significantly increased chemotaxis determined by 
counting the number of migrating cells within a 3um-pore-size filter. Determined as 
distance of migration within the filter, as chemotactic increment based on checkerboard 
analysis, as leukotactic index calculated on the basis of distance of migration and cell 
count at different depths within a 3-µm-pore-size filter, as distance of migration under 
agarose, and as the number of PMNs migrating across a 5-µm-pore-size filter, the 
chemotactic migration rates of PMNs of patients were similar to those of controls. 
Evaluation of the data on an individual basis suggested that in terms of PMN 
Chemotaxis, some patients were hyper responsive and some were hypo responsive. 
Chemotaxis, spontaneous migration and the rates of lipopolysaccharide-induced Tumour 
Necrosis Factor Alpha production by localized aggressive monocytes were similar to 
those of control cells. 
Zafiropoulos, Flores et al. (1991) 
71
 examined the oxidative metabolism of PMNs in 19 
RPP, 10 LJP, 10 AP and 39 healthy control subjects and was compared using the luminal 
chemiluminiscence (CL) method. In all groups, CL was significantly higher with 
autologous serum than with normal pooled serum and there was a significant linear 
relationship between the two values. There was a serum induced defect in 2 patients and 
1 control.
 
Schenkein, Best et al. (1991) 
58
 examined chemotaxis of PMNs from 492 subjects with 
various periodontal diagnoses and found that there was an influence of race on the 
chemotactic response of periodontally healthy individuals whether or not they were 
related to patients with Early Onset Periodontitis.
 
Ashkenazi, White et al. (1992) 
4
 carried out a study to determine if an extract of A. 
Actinomycetemcomitans could induce changes in PMN chemotaxis and showed that 
when neutrophils were preincubated with the bacterial extract, chemotaxis toward 
zymosan-activated serum, FMLP and the bacterial extract was inhibited in two different 
chemotaxis assays i.e. Boyden chamber and under agarose assay and suggested that A. 
Actinomycetemcomitans may contribute to the pathogenesis of localized aggressive by 
inhibiting chemotaxis. 
Biasi D, Bambara et al. (1999) 
9
 evaluated neutrophil function in patients suffering from 
the generalized form of early onset periodontitis (EOP). They concluded that neutrophils 
function in patients suffering from early onset periodontitis does not differ from control 
subjects, suggesting that the overall defence function of these cells  are normal. 
Kobayashi T, Sugita N et al. (2000) 
35 evaluated whether FcγR polymorphisms are 
associated with generalized early onset Periodontitis in Japanese patients. Thirty eight 
Japanese patients with G-EOP and 83 Japanese patients with aggressive periodontitis 
were included in study. FcγR genotypes for 3 bi-allelic polymorphisms were determined 
in these generalized early onset periodontitis and adult periodontitis and 104 races- 
matched healthy controls by means of allele’s specific polymerase chain reaction. There 
was a significant difference in the distribution of FcγRIIIb genotypes between G-EOP 
patients and healthy controls. The study indicates that FcγRIIIb-NA2 alleles could be 
associated with susceptibility to generalized early onset Periodontitis. 
Kazuyuki Shibata, Warbinton et al. (2001 )
36
 examined Nitric Oxide Synthatase (NOS) 
involvement in chemotaxis of normal neutrophils and NOS activity in neutrophils from 
10 normal subjects and 10 LAgP subjects .peripheral venous blood was isolated and 
membrane associated NOS and soluble NOS were extracted from cells with or without 
FMLP stimulation. NOS activity was measured using the radiolabeled L-arginine to L-
cit-rulline conversion assay and they suggested that NOS is present in human neutrophils 
and may be involved in FMLP induced chemotaxis in normal neutrophils and NOS 
activity is increased in LAgP and is negatively correlated to chemotaxis response. 
Loos et al. (2003) 
39
 evaluated the frequency of FcγRIIIb in 21 aggressive periodontitis 
patients and 26 healthy controls and found that FcγRIIIb-NA1/NA1 genotype in 
aggressive patients was significantly higher than in healthy control. 
Chung H-Y et al. (2003) 
15 
done a case-control study in which FcγRIIa, FcγRIIIa, 
FcγRIIIb in 32 aggressive patients, 72 chronic patients and 72 race-matched healthy 
controls in Japanese individuals. There was a significant over-representation of the 
FcγRIIIb-NA2 allele and FcγRIIIb 232 THr in the aggressive periodontitis group as 
compared with healthy control groups. No differences in FcγRIIa, FcγRIIIa 
genotype/allele distribution were demonstrated between the two groups. 
Nibali L et al. (2006)
 44 
done a case-control association study to test the association of 
specific gene polymorphisms affecting PMN functions with aggressive periodontitis. A 
blood sample was collected from subjects and genotypes p22
phox
 (CYBA) and FcγR were 
analyzed in a blind fashion. Results showed concomitant presence of C242T p22
phox
 
NADPH oxidase T allele and 
  FcγRIIIb-NA1 homozygosity was associated with 
generalized Aggressive phenotype in Caucasians.  C242T p22
phox
 NADPH oxidase and 
FcγR polymorphisms may predispose to Aggressive Periodontitis through modulation of 
neutrophils superoxide production.
  
A M Johnstone, Koh et al. (2007) 
5
 examined neutrophils function of 12 non-smoking 
patients who had been diagnosed with refractory Aggressive Periodontitis (RAP), 10 
patients with chronic Periodontitis  (CP), and 13 periodontally healthy controls (HCs). 
Their findings demonstrated a larger receptor independent respiratory burst and higher 
phagocytic activity in PMNs derived from patients with RAP compared to PMNs derived 
from CP patients and periodontally HCs. 
Shetty, Thomas et al. (2008) 
45
 evaluated neutrophils functions i.e. chemotaxis, 
superoxide production, phagocytosis and killing of Porphyromonas Gingivalis in 30 
diabetics and 30 non diabetic patients with chronic generalized Periodontitis relative to 
healthy and matched controls. Their analyses revealed a significant depression in the 
number of diabetic PMNs migrating along an FMLP gradient, significant enhancement of 
diabetic PMN superoxide production was observed and phagocytosis and killing by 
diabetic PMN of P. gingivalis was also impaired significantly. 
Carvalho, Mesquita et al. (2009) 
16
 evaluated the correlation between PMN 
phagocytosis and oxidative burst with the sub gingival microbiota of patients with 
Generalized Aggressive Periodontitis (GAgP). They concluded that GAgP subject 
presented diminished phagocytic activity of peripheral PMNs and high prevalence and 
levels of classical periodontal pathogens. No differences between groups were found for 
superoxide production. 
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                                  MATERIALS AND METHOD 
SOURCE OF DATA:  
This study was carried out on patients selected from the Out Patient Department, 
Department Of Periodontology, Tamilnadu Government Dental College and Hospital, 
Chennai. The study was carried out after the institutional ethical committee approval. The 
clinical material for the study consisted of 60 patients of either sex ranging in age 
between 13 - 60 years. 
INCLUSION CRITERIA: 
 Number of teeth present should not be less than - 20 
 Number of sites involved should have ≥ 2mm clinical attachment loss with 
presence of disease activity as recorded by Gingival index (LOE AND 
SILNESS) 
 Full mouth intraoral periapical radiographs were taken. 
 
EXCLUSION CRITERIA: 
 History of any systemic disease for the control group. 
 History of any systemic disease other than diabetes for the test group 
 Brittle diabetics. 
 Pregnant women and lactating mothers 
 Presence of any habits like smoking and alcoholism 
 History of antibiotic therapy within 6 months prior to study. 
 
 
SUBJECT STRATIFICATION:- 
 60 patients in the age group varying between 13-60 years from both sexes were selected. 
 60 patients were divided into four groups:- 
 Group I   –   15 Diabetic with Generalized chronic Periodontitis patients. 
 Group II –   15 Non Diabetic with Generalized chronic Periodontitis patients. 
 Group III – 15 Generalized Aggressive Periodontitis patients. 
 Group IV - 15 Control group of periodontally healthy patients 
 
SELECTION OF THE PATIENTS 
All the patients selected for this study were subjected to an intraoral examination under 
artificial light using a mouth mirror and William’s probe. Plaque index (SILNESS AND 
LOE 1964) and RUSSELL’S PERIODONTAL INDEX (1956) were used for the 
assessment of plaque and the periodontal condition of the patient. 
 
CRITERIA FOR SELECTION 
GROUP I - DIABETIC WITH GENERALIZED CHRONIC PERIODONTITIS 
3 
Patients selected for this group on the basis of the following features: 
      1. Age 13 to 60 years 
      2. Fasting plasma glucose should be equal or greater than 126mg/dl. 
      3. Generalized alveolar bone loss with multiple horizontal and vertical osseous 
          defects. 
 
 
GROUP II – NON DIABETIC WITH GENERALIZED CHRONIC                
                       PERIODONTITIS 
3
                                 
1. Age 30 -35 years or more 
2. Amount of microbial deposits is consistent with the severity of periodontal tissue 
Destruction 
3. Generalized severe alveolar bone loss with multiple horizontal and vertical      
osseous defects. 
4. Disease usually affects many teeth with no rapid progression of the disease 
 
GROUP III –   GENERALIZED AGGRESSIVE PERIODONTITIS 
13 
1. Include patients under 30 years of age or older,  
2.   Pronounced destruction of alveolar bone and generalized attachment loss 
affecting three permanent teeth other than first molar and incisors. 
3. Amount of microbial deposits is inconsistent with the severity of periodontal 
tissue destruction. 
4. Except for the presence of Periodontitis, patients are otherwise clinically healthy. 
.  
GROUP IV - CONTROL GROUP  
Periodontally healthy subjects who had Plaque and Russell’s Periodontal Index score 0 
were included in this group. 
A standard proforma consisting of the following data: Name, age, sex, past medical and 
dental history, plaque index (SILNESS AND LOE 1964) and RUSSELL’S 
 
PERIODONTAL INDEX (1956) and clinical attachment loss for the each patient was 
recorded. 
PLAQUE INDEX (Pl) (SILNESS AND LOE 1964) 
59 
Index used for assessment of plaque. It assesses only the thickness of plaque at the 
gingival area of the tooth. The surfaces examined are the four gingival areas of the tooth 
i.e. the disto-facial, facial, mesio-facial and lingual surfaces. The teeth and the gingiva 
were air dried and examined with mouth mirror and a dental explorer. Scoring criteria 
used is as follows: 
0 – The gingival area of the tooth surface is literally free of plaque. The surface is tested 
by running a pointed probe across the tooth surface at the entrance of the gingival crevice 
after the tooth has been perfectly dried. If no soft matters adhere to the point of probe, the 
area is considered clean. 
1 – No plaque can be observed in situ by the naked eye. A film of plaque adhering to the 
free gingival margin and adjacent area of the tooth which can be recognized only by 
running the explorer/pointed probe across the tooth surface or by using a disclosing 
agent. 
2 – A thin to moderate accumulation of soft deposits within the gingival pocket or on the 
tooth and gingival margin, which can be seen with the naked eye. 
3 – Abundance of soft matter within the gingival pocket and or on the tooth surface and 
gingival margin. The interdental area is stuffed with soft debris. 
 
Plaque index (Pl I) for a tooth – scores from four areas of tooth  
                                                                      4  
Nominal scale for patient evaluation: 
 
 
                
 
 
 
                                                                       
 
 
 
 
PERIODONTAL INDEX (PI) (RUSSELL 1956) 
59 
The PI was intended to estimate deeper periodontal disease by measuring the presence or 
absence of gingival inflammation and its severity, pocket formation, and masticatory 
function. 
All the teeth present are examined. All of the gingival tissue circumscribing each tooth is 
assessed for gingival inflammation and periodontal involvement. 
Calculation of the index: 
PI score per person = sum of individual scores 
                                    Number of teeth present 
 
 
 
SCORES RATING 
0 Excellent 
0.1-0.9 Good 
1.0-1.9 Fair 
2.0-3.0 Poor  
PI scoring criteria :  
SCORE CRITERIA  X-RAY CRITERIA  
0 NEGATIVE: there is neither overt 
inflammation in the investing tissues 
nor loss of function due to destruction 
of supporting tissues. 
Radiographic appearance is 
essentially normal. 
1 MILD GINGIVITIS: there is an 
overt area of inflammation in the free 
gingivae, but this area does not 
circumscribe the tooth. 
 
2 GINGIVITIS: inflammation 
completely circumscribing the tooth, 
but there is no apparent break in the 
epithelial attachment. 
 
4    There is early, notch like 
resorption of alveolar crest 
6  GINGIVITIS WITH POCKET 
FORMATION: the epithelial 
attachment has been broken and there 
is a pocket. There is no interference 
with normal masticatory function, the 
tooth is firm and has not drifted. 
There is horizontal bone loss 
involving the entire alveolar 
crest, up to half of the length of 
the tooth root. 
8 ADVANCED DESTRUCTION 
WITH LOSS OF MASTICATORY 
FUNCTION: the tooth may be loose, 
may have drifted, may sound dull on 
percussion with a metallic instrument, 
may ne depressible in socket. 
There is advanced bone loss, 
involving more than one half of 
the length of tooth root, or a 
definite infrabony pocket with 
widening of periodontal 
ligament. There may be root 
resorption or rarefaction at apex. 
 
 
Clinical conditions and periodontal scores: 
 
CLINICAL CONDITION GROUP PI SCORES  STAGE OF DISEASE 
Clinically normal  
supportive tissues 
0 – 0.2 
 
 
simple gingivitis 0.3 – 0.9 Reversible 
Beginning destructive  
periodontal disease 
 
0.7 – 1.9 
 
Reversible 
Established destructive  
periodontal disease 
 
1.6 – 5.0 
 
Irreversible 
Terminal disease 3.8 – 8.0 Irreversible 
 
 
COLLECTION OF BLOOD 
ARMAMENTARIUM 
  Disposable hypodermic syringes 
  23 gauge needle 
  Sterile vials  
  Tourniquet 
  Cotton swabs 
  Spirit 
Skin preparation was done and 5 ml of venous blood was drawn from the anticubital vein   
with a needle and a disposable syringe; 2.5 ml of the blood was transferred into a plain 
vial (for phagocytosis) and the remaining 2.5ml into the vial containing Heparin and 
transported immediately to the laboratory in a box containing ice pack. 
TESTING FOR NEUTROPHIL FUNCTIONS 
41, 46, 43, 60, 71 
 The patients selected for the present study underwent the following neutrophils function 
tests 
1. CHEMOTAXIS 
2. PHAGOCYTOSIS 
3. SPECIFIC GRANULE RELEASE ESTIMATION. 
 
                                                                 
 
 
 
NEUTROPHIL CHEMOTAXIS ASSAY 
 DETAILS OF TECHNIQUE: 
UNDER AGAROSE TECHNIQUE 
41, 46 
Migration of neutrophils in response to chemoattractant in the environment is carried out 
by using viable cells suspended in a balanced salt solution (Hank’s) or Minimal Essential 
Media (MEM) using agarose technique. 
PREPARATION OF CELLS 
Blood was drawn into sterile disposable syringe with 10 -20 unit of Heparin per ml of 
blood   erythrocytes were sedimented by gravity at 37
0
c. The blood was centrifuged at 
2000 RPM for 30 minute and polymorphs obtained. 
EQUIPMENT  
       1) 37
◦
C Incubator  
       2) A means for low power magnification 
REAGENTS: 
       1.2G/ml agarose  
       120 mg agarose powder was dissolved in 5ml distilled water by heating it 10-15  
        min and cooled to 48
0
C for   
 
SUPPLEMENTED   
      a)    100 µl of 10x MEM 
      b)   100 µl of heat inactivated pooled human serum 
      c)   100 µl 7.5% sodium bicarbonate 
      d)   2.9 ml distilled water 
      3. 10 
-8
 M FMLP as chemoattractant was used  
STAINING REAGENT used were 
       A)    2 to 3 ml methanol 
       B)    2 to 3 ml formalin 
       C)    Wrights stain 
PREPARATION OF AGAROSE PLATE 
120 mg of agarose powder was dissolved in 5ml distilled water by heating it for10-15 
minutes and cooled to 48
0
c. The agarose was mixed with an equal volume of prewarmed 
MEM and fetal calf serum mixture whose p
H
 was brought to alkalinity with sodium 
bicarbonate. 6 ml of the agarose medium was layered onto the rectangular glass slide and 
allowed to harden for half an hour to facilitate the cutting of wells. 
PREPARATION OF AAROSE WELLS  
1. Series of three wells 3mm in diameter were cut and spaced 3mm apart for this 
purpose and 11 gauge punches such as Pasteur pipette attached to a vacuum was 
used 
2. Arrangement of wells for agarose chemotaxis assay  
 
 
 
      a. FMLP chemoattaractant 
      b. White blood cells 
      c. MEM   
      d. Serum 
METHOD FOR CHEMOTAXIS 
      1.  0.01ml of FMLP chemoattaractant was added to A well 
      2.  0.01ml of WBC was added to B well 
      3.  0.01ml MEM was added to C well 
      4.  0.01 ml serum was added to D well 
PMN’s were incubated for 370C for 2 hours. After incubation, cells were fixed and 
stained which are as follows:  
      a. Culture plates were flooded with 3-5 ml methanol for 30 min and removed. 
      b. 3 -5 ml formalin was flooded for 30 min. 
      c. Agarose was removed. 
      d. WBC’s were stained on bottom of culture plates with Wright’s stain for 15 min  
          and washed with distilled water. 
CALCULATION: 
      1. Culture plates were projected under the microscope. 
      2. Chemotaxis was measured as linear distance (in cm) that WBC cells (from B)    
          have migrated from margin of well toward FMLP chemoattractant (A). 
            
 
            
 PHAGOCYTOSIS ASSAY:
 43, 60 
Suspension of killed spore’s Candida albicans was incubated with buffy coat preparation 
of leukocytes. The number of Candida spores internalized by each phagocyte was then 
counted under the microscope from smears of centrifuged deposits. Complement factors 
needed for phagocytosis were provided by pooled serum and the leukocyte was kept 
viable in Hank’s Balanced Salt Solution. 
MATERIALS 
      1. Leukocytes suspended in Hank’s Balanced Salt Solution. 
      2. Hank’s Balanced Salt Solution. 
      3. Candida albicans suspension.  
Candida cells suspended in Hank’s solution at a concentration of 5 x106 cells/ml. The 
yeasts were killed by heating at 100 
0 
C for 30 mins. A large batch was thus prepared and 
divided into small aliquots sufficient for each test. These were stored at -20
0
C until use. 
     4. Pooled Human serum 
     5. Phosphate Buffered Saline (PBS) 
METHOD 
A sets of test tubes which include 0.25ml Hank’s solution, 0.25 ml pooled human serum, 
0.25ml of heat killed Candida and 0.25ml leukocytes suspension were added. The test 
tubes were incubated at 37
0
C for 30 minutes. Then they were centrifuged at 2000 RPM 
for 30 minutes and the supernatant was removed with a Pasteur pipette leaving a droplet 
into which the sediment was resuspended. Smears were made air dried and stained with 
Wright’s stain. 100 neutrophils were examined and the number of neutrophils positive for 
Candida ingestion counted.  The number of Candida spores ingested per cell was also 
counted. Phagocytosis was thus expressed as the number of particle internalized per 100 
neutrophils. 
RESULT:  
Normal neutrophils may contain anything from no Candida to five or more per cell. A 
normal control tested at the same time as the patient’s cells and any difference is noted. 
SPECIFIC GRANULE RELEASE ASSAY 
71 
Specific granule release from stimulated human neutrophils was done using qualitative 
test by Nitro Blue Tetrazolium (NBT) test. 
MATERIALS USED: 
      1. Phosphate Buffered Saline (PBS) P
H
 -7.2 
      2. Endotoxin (E.Coli-H sigma Chemicals, U.S.A.) 
      3. Heparin 150 to 200 Unit/ml of blood 
 The endotoxin is made up as a solution of 1mg/ml in PBS. 
0.1ml of endotoxin is added to the NBT and heparinised blood mixture for stimulation of 
cells. 
METHOD 
 2ml of venous blood was collected and 200 unit of Heparin added as an anticoagulant.6 
drops of working NBT solution were added to 6 drops of Heparinised blood and gently 
mixed. The mixture was incubated at 37
0
C for 30 mins. At the end of 30 minutes the 
solution was gently mixed and cover-slip smears were made. The smears were dried and 
stained with Wright’s stain. The stained smear was then examined under oil immersion 
objective and neutrophils with ingested, blue or bluish-black formazan crystals were 
counted. A total of 100 neutrophils were counted and the percentage of positive 
neutrophils noted. The test was mathematically expressed as the number of neutrophils 
out of 100 that were positive for NBT reduction. 
RESULT: 
Less than 10% of normal unstimulated neutrophils contain blue granules. Stimulated cells 
may be over 90% positive. 
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           Measurements of probing depth with William’s periodontal probe                                
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Photograph of Radiographs of Group II 
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Photograph of Radiographs of Group III 
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Photograph of Radiographs of Group IV 
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     Armamentarium used for periodontal examination and blood sample collection 
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Collection of the venous blood sample 
 
Photograph No. 12 
 
 
     Armamentarium for sample transportation 
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Armamentarium used for neutrophil function test 
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Microscope 
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Centrifuge Machine 
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Photomicrograph showing neutrophil migrating towards chemoattractant- low 
power 
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Photomicrograph showing neutrophil migrating towards chemoattractant- High 
power 
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Photomicrograph showing neutrophil phagocytosis of candida 
Photograph No. 20 
 
Photomicrograph showing formazan crystal inside neutrophil (NBT Reduction) 
 
 
 
 
STATISTICAL ANALYSIS 
 
 The statistical package SPSS PC + (Statistical Package for Social Science, 
Version 4.0.1) were used for statistical analysis. 
 Analysis of variance (ANOVA) followed by Tukey – HSD test was the 
technique used in this study to compare the mean values between control, study group A 
and B. ANOVA is used to test equality of means, when more than two populations are 
considered. 
 A set of N = Cr observations classified in one direction may be represented as 
follows: 
 
   X1r X2r Xcr 
Mean =  
   X1 X2 Xc 
 
   X1  +  X2 + ....... Xc 
X =  
    C 
Then 
 `Between column' sum of squares: SSC =   2 
j
j XX  
 `Within column' sum of squares: SSE =   2 
j
jij
i
XX  
Total sum of squares: SST =   2  jXX j  
SST = SSC + SSE 
                                     Tukey’s HSD Post Hoc Test Steps 
 
 
 
 
FORMULA: 
 
M = 
treatment/group 
mean 
n = number per 
treatment/group 
Steps  
1. Calculate an analysis of variance (e.g., One-way between-subjects ANOVA).  
2. Select two means and note the relevant variables (Means, Mean Square Within, 
and number per condition/group)  
3. Calculate Tukey's test for each mean comparison  
4. Check to see if Tukey's score is statistically significant with Tukey's 
probability/critical value table taking into account appropriate df within and 
number of treatments.  
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                                                  RESULT 
 
      In the present study, 60 subjects were included, among them 15 Diabetic with  
Generalized Chronic Periodontitis were categorized as Group I, 15 Non Diabetic 
patient with Generalized Chronic Periodontitis were categorized as Group II, 15 
Generalized Aggressive Periodontitis were categorized as Group III, and healthy 
control as Group IV. The clinical parameters used were plaque index, periodontal 
index, probing depth and clinical attachment loss. 
The neutrophils function tests were performed under identical condition for the 
entire sample. The individual score for each test for each sample were calculated 
and finally, the mean values and standard deviation obtained for all three tests in 
all four groups. 
The results were subjected to statistical analysis using ANOVA followed by 
Tukey HSD. 
Table no.1 & Figure 1 Shows the comparison of mean and standard deviation of 
plaque index. It was found that plaque index was less in Group I and in Group III 
as compared to Group II with mean value of  2.273 ± 0.1533  for Group I, 2.800 ± 
0.2181 for Group II, 1.353 ± 0.155 for Group III and 0 for Group IV with p value 
<0.001 which is highly significant statistically. 
Table no.2 & Figure 2 Shows the comparison of mean and standard deviation of 
periodontal index. It was found that periodontal  index was more in Group I and in 
Group III as compared to Group II with mean value of 4.166 ± 0.134  for Group I, 
3.813 ±  0.130 for Group II, 6.126 ± 0.162 for Group III and 0 for Group IV with 
p value <0.001 which is highly significant statistically.  
 
Table no.3 & Figure 3 Shows the comparison of mean and standard deviation of 
neutrophil chemotaxis between four groups. It was found that  neutrophil 
chemotaxis was defective in Group I and in Group III as compared to control and 
Group II with mean value was 1.340 ± 0.2028 for  Group I, 2.747 ± 0.130 for  
Group II, 1.287 ± 0.135 , for Group III, and 2.76 ± 0.129 for Group IV, with 
P<0.001 which was statistically highly significant. 
Table no.4 Shows the multiple comparison of mean and standard deviation of 
neutrophil chemotaxis between four groups. 
Table no.5 & Figure 4 Shows the comparison of mean and standard deviation of 
neutrophil phagocytosis between four groups. It was found that  neutrophil 
phagocytosis was defective in Group I, Group II, and in Group III as compared to 
control with mean value of  187.33± 6.207, for group I, 281.40 ± 6.057,for group 
II , 277.13 ± 4.373 for Group III and 296 ± 4.367 for Group IV with P>0.001 
which was statistically significant. 
Table no.6 Shows the multiple comparison of mean and standard deviation of 
neutrophil phagocytosis between four groups. 
Table no.7 & Figure 5 Shows the comparison of mean and standard deviation of 
Specific Granules Release between four groups. It was found that granules release 
was defective in Group I as compared to control with mean value 77.87 ± 2.295, 
for Group I, 80.13 ± 3.021 for Group II, 78. ± 2.449 for Group III and 81.87 ± 
2.326 for Group IV with P>0.001 which was statistically significant. 
Table no.8 Shows the multiple comparison of mean and standard deviation of 
Specific Granules Release assay among four groups. 
 
Note 
P value 
0 to 0.01     -            ** significant at 1% level 
0.011 to 0.05 -           * significant at 5% level 
> 0.05                           not significant at 5% level 
 
 
 
 
 
 
 
 
 
 
                                                 TABLE NO.1 
 
COMPARISON OF MEAN & STANDARD DEVIATION OF PLAQUE 
INDEX    BETWEEN FOUR GROUPS 
 
 
 
Group N Mean 
St 
Deviation 
P Value 
Group I 15 2.2733 .15337  
< 0.001** 
 
Group II 15 2.8000 .21381 
Group III 15 1.3533 .15523 
Group IV 15 .0000 .00000 
 
                                                        TABLE NO.2 
 
COMPARISON OF MEAN & STANDARD DEVIATION OF 
PERIODONTAL INDEX BETWEEN FOUR GROUPS 
 
 
Group N Mean 
Std. 
Deviation 
P Value 
Group I 15 4.1667 .13452  
 
< 0.001** 
Group II 15 3.8133 .13020 
Group III 15 6.1267 .16242 
Group IV 15 .0000 .00000 
 
 
 
                                                         TABLE NO. 3 
 
 
COMPARISON OF MEAN & STANDARD DEVIATION OF 
CHEMOTAXIS AMONG FOUR GROUPS 
 
 
 
 
                                                         TABLE NO. 4 
 
MULTIPLE COMPARISONS OF MEAN & STANDARD DEVIATION OF 
CHEMOTAXIS BETWEEN FOUR GROUPS 
 
 
 Group (J) Group Mean Difference 
(I-J) 
Std. Error P value 
Group I Group II -1.407(*) .0557 <0.001** 
 Group III .053 .0557 <.774 
 Group IV -1.427(*) .0557 <0.001** 
Group II Group I 1.407(*) .0557 <0.001** 
 Group III 1.460(*) .0557 <0.001** 
 Group IV -.020 .0557 .984 
Group III Group I -.053 .0557 .774 
 Group II -1.460(*) .0557 <0.001** 
 Group IV -1.480(*) .0557 <0.001** 
Group IV Group I 1.427(*) .0557 <0.001** 
 Group II .020 .0557 .984 
 Group III 1.480(*) .0557 <0.001** 
 
 
Group N Mean Std. Deviation 
P Value 
Group I 15 1.340 .2028  
 
<0.001** 
Group II 15 2.747 .1302 
Group III 15 1.287 .1356 
Group IV 15 2.767 .1291 
Total 60 2.035 .7431 
                                                        TABLE NO. 5 
 
COMPARISONS OF MEAN & STANDARD DEVIATION OF 
PHAGOCYTOSIS   BETWEEN FOUR GROUPS 
 
Group N Mean Std. Deviation 
P value 
Group I 15 187.33 6.207 
<0.001** 
Group II 15 281.40 6.057 
Group III 15 277.13 4.373 
Group IV 15 296.73 4.367 
 
                                                        TABLE NO. 6 
 
MULTIPLE COMPARISONS OF MEAN & STANDARD DEVIATION OF 
PHAGOCYTOSIS BETWEEN FOUR GROUPS 
 
Group (J) Group 
Mean Difference 
(I-J) Std. Error P value 
Group I Group II -94.07(*) 1.944 <0.001** 
 Group III -89.80(*) 1.944 <0.001** 
 Group IV -109.40(*) 1.944 <0.001** 
Group II Group I 94.07(*) 1.944 <0.001** 
 Group III 4.27 1.944 .137 
 Group IV 
-15.33(*) 1.944 <0.001** 
Group III Group I 89.80(*) 1.944 <0.001** 
 Group II -4.27 1.944 .137 
 Group IV -19.60(*) 1.944 <0.001** 
Group IV Group I 109.40(*) 1.944 <0.001** 
 Group II 
15.33(*) 1.944 <0.001** 
 Group III 19.60(*) 1.944 <0.001** 
 
 
                                                          TABLE NO. 7 
 
COMPARISONS OF MEAN & STANDARD DEVIATION OF SPECIFIC 
GRANULE RELEASE ASSAY BETWEEN FOUR GROUPS 
 
 
                                                         TABLE NO.8  
 
MULTIPLE COMPARISONS OF MEAN & STANDARD DEVIATION OF 
SPECIFIC GRANULE RELEASE ASSAY BETWEEN FOUR GROUPS 
 
 
 
 Group (J) Group Mean 
Difference (I-J) 
Std. Error P value 
Group I Group II -2.27 .927 .080 
 Group III -.13 .927 .999 
 Group IV -4.00(*) .927 <0.001** 
Group II Group I 2.27 .927 .080 
 Group III 2.13 .927 .110 
 Group IV -1.73 .927 .253 
Group III Group I .13 .927 .999 
 Group II -2.13 .927 .110 
 Group IV -3.87(*) .927 .001 
Group IV Group I 4.00(*) .927 <0.001** 
 Group II 1.73 .927 .253 
 Group III 3.87(*) .927 .001 
Group N Mean Std. Deviation P Value 
Group I 15 77.87 2.295  
 
< 0.001** 
Group II 15 80.13 3.021 
Group III 15 78.00 2.449 
Group IV 15 81.87 2.326 
Figure: 1 
 
COMPARISON OF MEAN PLAQUE INDEX BETWEEN FOUR GROUPS 
 
 
 
 
 
                                                              Figure: 2 
 
COMPARISON OF MEAN PERIODONTAL INDEX BETWEEN FOUR 
GROUPS 
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COMPARISON OF MEAN CHEMOTAXIS BETWEEN FOUR GROUPS 
 
 
 
 
 
                                                            Figure - 4 
 
COMPARISON OF MEAN PHAGOCYTOSIS BETWEEN FOUR GROUPS 
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COMPARISON OF MEAN SPECIFIC GRANULE RELEASE AMONG 
FOUR GROUPS 
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                 DISCUSSION 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
      The probable influence of diabetes mellitus on the onset and duration of periodontal 
disease has been studied for many years. On the basis of experimental and clinical 
investigations, it is generally accepted that diabetes may result in a greater severity of 
periodontal disease. The mechanism of increased susceptibility to periodontitis in 
diabetics is not entirely clear. According to a few investigators, the primary factor 
responsible for the development of diabetic complications is prolonged tissue response to 
hyperglycemia, which results in the production of advanced glycated end products. Also, 
there may be an increase in the local production of cytokines leading to connective tissue 
damage, bone resorption and delayed wound repair. Several studies in diabetic humans 
have reported defects in neutrophil functions namely chemotaxis, phagocytosis, killing 
and microbicidal and super oxide released, which could be one of the reasons for 
increased susceptibility to Periodontitis in these subjects.
10, 18,,24 ,25,7 
      Periodontitis is a disease attributable to multiple infectious agents and interconnected 
cellular and humoral host responses. It is widely accepted that bacteria or bacterial 
substances of the dental plaque are the primary etiologic factors in the initiation of 
inflammatory periodontal disease. The specific microflora composition in periodontal 
pocket is important in determining the severity and extent of destruction to the 
periodontium. However, an individual’s susceptibility may be an additional and 
important modifying factor in the pathogenesis of periodontitis.
47 
      In the last decade it has been established that increased susceptibility to certain 
periodontal diseases is associated with decreased leukocyte numbers and/or functional 
capabilities. In addition, there appears to be an association between aggressive forms of 
periodontitis and certain hereditary disorders. Few studies have also shown the 
association of neutrophil functions in Chronic Periodontitis. Aggressive Periodontitis 
comprises a group of rare, often severe types of periodontal diseases that affect mainly 
young patients, occur in localized and generalized forms, have a rapid attachment loss 
and bone resorption, and are marked by familial aggregation. Chronic Periodontitis 
group, manifests a later onset, usually during the fourth or fifth decade of life, and has a 
much slower rate of progression.
3, 13 
      Over the years, data supporting the microbial etiology of periodontal diseases have 
led to the recognition of several periodontally pathogenic species. PMNs form the first 
line of defense against these periodontal pathogens in the gingival sulcus. At this site, 
PMNs are actively involved in phagocytosing and killing bacteria through degranulation 
of enzymes and production of oxygen radicals. The phagocytosis of bacteria at this 
interface is enhanced dramatically by specific antibody recognition. There is clear 
evidence of the importance of this protective PMN barrier, as patients with abnormalities 
in the numbers and/or functions of these cells often experience rapid and severe 
periodontal destruction. PMN dysfunctions have also been associated with recurrence of 
disease after treatment. The concept that PMNs are important protective cells is further 
supported by the fact that many periodontal organisms possess virulence factors that 
suppress neutrophils activities. It remains unclear whether neutrophil impairment is an 
intrinsic characteristic in patients with severe destructive diseases. The current study 
aimed to assess neutrophil functions i.e. Chemotaxis, Phagocytosis and Specific Granule 
Release in Diabetic and Non Diabetic patient with Generalized Chronic Periodontitis and 
in Generalized Aggressive Periodontitis patients. 
      The present study was carried out in 60 subjects comprising of both males and 
females reporting to the department of Periodontics in Tamil Nadu Government Dental 
College and Hospital, Chennai.  The subjects were divided into four equal groups based 
on their periodontal status according to various clinical parameters which included plaque 
index, and periodontal index, probing depth, clinical attachment level and neutrophils 
functions that included Chemotaxis under agarose technique, Phagocytosis of killed 
Candida albicans and Specific Granule Released using Nitro Blue Tetrazolium Test 
(NBT). 
      In exclusion criteria of this study we took account of many factors that affects the 
neutrophils functions. We have excluded chronic smokers, tobacco users from our study 
as it may affect neutrophils chemotaxis. It is corroborates with the study done by 
Margereta et al 1999 who showed that smoking per se induces several changes in the 
blood increased radical changes in peripheral neutrophils, decreased chemotaxis, 
phagocytosis, imbalances between plasma proteases and oxidants. 
      Female patients on contraceptives, menstruation and pregnancy were excluded as it 
might have an effect on phagocytic activity of PMNs. The influence of gender on 
neutrophil functions remains uncertain; however, data using animal models indicated that 
sexual hormones seem to have different effects on chemotactic, phagocytic activities of 
PMNs.
40 
      When the periodontal status of Group IV( periodontally healthy subjects) was 
compared with that Group I ( Diabetic with Generalized Chronic Periodontitis) Group II( 
Non Diabetic with Generalized Chronic Periodontitis) and Group III (Generalized 
Aggressive periodontitis) subjects , the amount of local factors was less and periodontal 
destruction was more in Group I and Group III subjects as compared to Groups II. The 
mean plaque score for Group I was 2.273 ± 0.1533 and for Group III 1.353 ± 0.155 
which was significantly less in  Group I and in Group III  than  Group II which was 2.800 
± 0.218. This finding in our study was in agreement with studies done by  Listgarten et 
al 
42 
who reported a significantly less plaque plaque score in diabetics and also with Van 
Dyke et al, Offenbacher et al 
64
 who reported a significantly less plaque score in GAgP 
subjects. The mean periodontal index score 6.126 ± 0.162 was significantly more in 
Group III than Group I which was 4.166 ± 0.134 and  Group II which was 3.813 ±  0.130. 
This finding in our study was in agreement with Heikki Repo et al 
27
; Van Dyke et al; 
Offenbacher et al 
64
 who showed that mean periodontal index score was more in GAgP 
patient. Our findings were compatible with the expected clinical findings of patients with 
aggressive periodontitis.  
      The present study evaluated the comparison between peripheral PMN chemotaxis, 
phagocytosis and specific granule release among four groups. Our data showed that in  
Group I and Group III  subjects, most exhibited defective chemotaxis towards FMLP 
chemoattractant as compared to Group II  and  Group IV (periodontally healthy control 
subjects) (fig ). And good chemotaxis towards FMLP was observed in Group II and 
Group IV subjects with periodontally healthy subjects (fig). The mean chemotaxis 
between FMLP of  Group I was 1.340 ± 0.2028, group II was 2.747 ± 0.130 Group III 
was 1.287± 0.135 and 2.767 ± 0.129 for Group IV with P<0.001 which was statistically 
highly significant. These results extend and confirm earlier studies in which defective 
PMNL chemotaxis was reported in GAgP patient by Cianciola et al 
62
, by Clark et al 
14
 
and by Lavine et al 
37
. Our study also in agreement with study done by Christopher W 
Cutler et al 
19 
       It has become apparent in recent years that GAgP subjects are not a totally 
homogenous group with regard to neutrophils function. Many laboratories agree that 
neutrophils chemotaxis is depressed in 65-75% of GAgP patients. However reports of 
population of GAgP patients with no detectable neutrophils abnormalities also appear. 
The most likely explanation for these discrepancies is population differences, in that the 
groups without abnormalities were genetically homogenous. Since GAgP subjects exhibit 
a geographic variation we carried out this study in Indian population and confirmed the 
chemotaxis defect in such patients. 
      The chemotaxis defect in Group II subjects was less as compared to GAgP subjects 
and was similar as compared to periodontally healthy subjects and was not statistically 
significant. Whereas results showed that chemotaxis was defective in Group III ( GAgP)  
patients as compared to Group II  and periodontally healthy subjects and was highly 
significant statistically. This proved that chemotaxis was not significantly defective in 
Group II subjects like GAgP subjects. This finding is in agreement with Tufano et al 
1992.
67 
      An interesting aspect of patients with GAgP is that they appear to be otherwise 
healthy. Nevertheless, about 75% of aggressive periodontitis patients have shown to have 
abnormal leukocyte chemotactic behavior. During the last decade, however, it has 
become increasingly clear that many patients with Aggressive Periodontitis may either 
fail to display any leukocyte chemotactic defect or their cells may actually display 
enhanced chemotactic ability. There are three main sources of variability which may 
explain these discrepancies are: 
1. Variations in clinical diagnostic criteria 
2. Individual variability 
3. Technical variation 
      Several methods are available for studying cell locomotory behaviour, of which the 
two most common are Boyden chamber technique and the under agarose migration 
method Chemiluminescence (CL) is also one of the methods by which neutrophils 
functions can be evaluated. In the Boyden chamber technique cells penetrate a porous 
filter and they are to some extent contact guided to some extent by the pores themselves.   
Under agarose migration method, the cells move on a 2 dimensional surface in the 
junctional plane between a plastic tissue culture dish and an overlaying agarose gel.
41, 46
.  
Chemiluminiscence is the light energy produced by the PMN during its interaction with 
bacteria or other particles. The method used in this study was under agarose migration 
method due to its relatively simple and practical system to use, in that it requires no 
special equipment like in Boyden chamber or Chemiluminescence and it uses low 
numbers of cells and small amounts of chemoattractant substances. 
      The present study also evaluated the comparison between peripheral PMN 
phagocytosis using killed Candida albicans among four groups. Our data revealed that  
Group I, Group II, and Group III patients showed significant difference in phagocytosis 
rate as compared to  Group IV (periodontally healthy control group). The mean 
phagocytosis between group I was 187.33± 6.207, in group II was 281.40 ± 6.057, group 
III was 277.13 ± 4.373, and296 ± 4.367with P>0.001 which was statistically significant. 
      Our finding was in agreement with studies of  Cianciola et al 1977,
62
 Van Dyke et al 
1986,
64
 Kimura et al 1992 Eick et al 2000 who showed that GAgP patients presented a 
significantly diminished phagocytosis rate of opsonised bacteria compared with 
periodontally  healthy  subjects. Our  finding  also in  agreement with study by    Cutler 
et al 
19 
who found impaired phagocytosis in diabetic patient. 
      When specific granule release was assayed using stimulated cells in the presence of 
Nitro Blue Tetrazolium (NBT) dye, it was found that stimulated cells from all the three 
groups showed that the dye was taken up into phagosomes and intracellular reduction of 
dye converted it into an insoluble blue crystalline form which was visible in light 
microscope. The NBT stimulated for Group I was 77.87 ± 2.295, for Group II was 80.13 
± 3.021 for group III was 78. ± 2.449 and for Group IV was 81.87 ± 2.326 with 
P>0.001which was statistically significant. 
      This suggested that Group I subjects were less able to reduce NBT as compared to 
healthy controls. This is in agreement with the study done by Veta et al 1993
 69
. But 
when Group II, and Group III subject were compare with group IV the values for the test 
group did not differ significantly from the control group. This shows that the neutrophils 
in this condition are not metabolically defective. Our observations are in agreement with 
the study done by Shurine et al 
61 
in 1979 and Zafiropoulas in 1988.
71
 and also with 
Van Dyke et al in 1986.
64 
      Conflicting data among the present study and other studies may have resulted from 
differences in study population, assays for chemotaxis, phagocytosis, specific granule 
release detection. One possible limitation of our study may have been the small size of 
the sample population. Another aspect that should be considered in this study is related to 
the criteria used for the diagnosis of periodontal disease or health. This has been a 
controversial issue in many clinical and microbiological studies in Periodontology. There 
is a consensus that the classification and diagnosis of diseases such as periodontitis 
should be based on clinical, environmental and laboratory parameters related to host 
microbial interactions. However, at the moment the definition of periodontal health or 
disease continue to rely on well described clinical criteria that the level of disease of a 
particular population.
3, 13 
      Thus it can be suggested that the assessment of neutrophils functions viz, chemotaxis, 
phagocytosis rate, specific granule release may be an important and useful tool for 
explaining various types of periodontal pathologies. Defective neutrophil function may 
play an important role in the induction and pathogenesis of severe periodontitis in young 
individuals. Disease resulting in destruction of periodontal support such as seen in 
aggressive periodontitis may be due to decreased capabilities of selected aspects of 
neutrophils function. 
 
 
 
               
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY AND CONCLUSION 
 
 
 
 
 
 
 
 
 
                                SUMMARY & CONCLUSION 
      Periodontal diseases have a multifactorial aetiology and microbial infections play a 
prominent role in the pathogenic process. Neutrophils are the key cellular elements of the 
innate immune system, providing protection from invading bacteria. Functional defects in 
peripheral PMNs have also been implicated in the pathogenesis of Periodontitis. 
Evidence for the protective function of PMNs in periodontal disease comes from the 
observations that individuals with severe periodontitis exhibit quantitative and/ or 
qualitative defects in their peripheral PMNs. 
1, 30 
      The aim of the present study was to assess Neutrophil functions i.e. Chemotaxis, 
Phagocytosis and Specific Granule Release in patients with diabetic and non diabetic 
patients with generalized chronic periodontitis and in generalized Aggressive 
Periodontitis in Indian population. 60 patients were selected to participate in the study 
which was divided into four groups. These patients were selected according to clinical 
and radiographic criteria. Blood samples from 60 patients were collected after drawing 
5ml peripheral venous blood and then various assays were carried out to assess the 
neutrophils functions mentioned above. Statistical analysis of the results was done using 
ANOVA followed by Tukey HSD test. 
 
 
 
 
Following conclusions were drawn from the present study: 
1. Statistically highly significant differences were found in the Chemotaxis of 
Diabetic with Generalized Chronic Periodontitis and in Generalized Aggressive 
Periodontitis subjects as compared to Non Diabetic with Generalized Chronic 
Periodontitis subjects and periodontally healthy control subjects. 
2. Statistically highly significant difference was observed in the Phagocytosis rate of 
Diabetic and Non Diabetic with Generalized Chronic Periodontitis and in 
Generalized Aggressive Periodontitis subjects, when compared to periodontally 
healthy control subjects. 
3. A statistically highly significant difference between the Specific Granule Release 
using stimulated Nitro Blue Tetrazolium test were observed in Diabetic with 
Generalized Chronic Periodontitis  subjects when compared to periodontally 
healthy control subjects. 
      Although, these findings do favour that defects or diminished activity in PMNs are 
also one of the factors that are responsible for the pathogenesis of periodontal diseases, 
and also a possible mechanism to render diabetic patients are more susceptible to 
periodontal diseases.
24
 Further longitudinal and clinical trials with larger sample size and 
newer sensitive techniques are needed. 
           To summarise, in the present study the chemotaxis and phagocytic defect was 
detected in diabetic and GAgP subjects which showed that there was a cellular intrinsic 
defect in such subjects and also significant differences in reduction in specific granule 
release using qualitative stimulated NBT was detected in diabetic subject which showed 
that normal microbicidal activity was reduced in infection and intracellular killing 
capacity of neutrophils was reduced. The important role of PMNs play in optimal 
functioning of the immune defence system has led to speculation that a partly 
compromised system could severely weaken the defence mounted against a bacterial 
insult and permit the occurrence and progression of infections and play an important role 
in induction and pathogenesis of periodontal diseases.
17
 The role of neutrophils functions 
in the aetiology and pathogenesis of destructive periodontal disease merits further 
investigation. 
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                                     DEPARTMENT OF PERIODONTICS 
 
TAMILNADU GOVERNMENT DENTAL COLLEGE AND HOSPITAL, 
         CHENNAI  600003. 
 
Comparison of neutrophil function in diabetic and non diabetic patients 
with generalized chronic periodontitis and in generalized aggressive 
periodontitis patients and to compare this study in healthy control 
group. 
                                                                      
            PROFORMA 
 
 
Date:    Dental O.P. No:    Code No: 
 
Name:                                                                Age / Sex: 
 
Address:             Tel. no:              Mobile no: 
 
        Occupation:    Income: 
 
 
Chief Complaints: 
Pain / Shaky teeth / Bleeding gums / Swollen Gums / Receding Gums / Pus 
Discharge / Increase in Spacing between teeth / Stains / Others. 
 
Duration: 
Medical history: 
 
1. Diabetes Mellitus 
2. Pregnancy / Lactation 
3. Cardiac diseases 
4. Stroke 
5. Any drugs against hypercholesterolemia 
6. Liver dysfunction 
 
Dental history: 
 
      Periodontal treatment within past 6 months. 
 
 
       Clinical Examination:    
 
PLAQUE INDEX – SILNESS AND LOE (1964) 
 
 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
 
 
   Calculation = 
 
 
 
Inference    = 
 
   
PERIODONTAL INDEX:  (RUSSELL, 1956) 
 
 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
     
                 PI = 
PROBING DEPTH (PD) AND CLINICAL ATTACHMENT LEVEL 
(CAL)      
  
MAXILLARY:    
     Palatal 
CAL                 
PPD                 
 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
PPD                 
CAL                 
     Buccal 
 
MANDIBULAR: 
     Lingual 
CAL                 
PPD                 
 48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
PPD                 
CAL                 
     Buccal 
 
 
 
DIAGNOSIS 
 
 
 
 
Sample details: 
 
Site: 
Date: 
 
INVESTIGATION:  
IOPA X- ray 
OPG 
 
 
 
RADIOGRAPHIC FINDINGS: 
DISTRIBUTION: 
PATTERN OF BONE DESTRUCTION: 
 
 
 
NEUTROPHIL FUNCTION TEST: 
- CHEMOTAXIS  
- PHAGOCYTOSIS  
- SPECIFIC GRANULE RELEASE ASSAY 
 
 
 
INFERENCE: 
 
 
 
 
Signature of P.G student 
 
Date: 
Time: 
 
 
 
 
 
 
 
 
 
 
 
                                            INFORMED CONSENT FORM 
 
         
 
STUDY TITLE: 
 
COMPARISON OF NEUTROPHIL FUNCTIONS IN DIABETIC AND NON 
DIABETIC WITH GENERALIZED CHRONIC PERIODONTITIS AND IN 
GENERALIZED AGGRESSIVE PERIODONTITIS PATIENTS AND TO 
COMPARE THIS STUDY IN HEALTHY CONTROL GROUP. 
  
Name:        O.P.No: 
 
  
Address:                  Code No: 
 
                  Age / Sex:  
        
  
 I,___________________________________________________age____years 
exercising my free power of choice, hereby give my consent to be included as a 
participant in the study “”  comparison of Neutrophil function in diabetic  and non 
diabetic patient with generalized chronic periodontitis and in generalized aggressive 
periodontitis patients and to compare this study in  control group . 
I agree to the following: 
  
 I have been informed to my satisfaction about the purpose of the study and study 
procedures including investigations to monitor and safeguard my body function. 
 I understand that the lab investigations will require the procurement of my blood 
in required amount. 
 I agree to cooperate fully and to inform my doctor immediately if I suffer any 
unusual symptom. 
 I have informed the doctor about all medications I have taken in the recent past 
and those I am currently taking. 
 I hereby give permission to use my medical records for research purpose. I am 
told that the investigating doctor and institution will keep my identity 
confidential. 
 
                
Name of the patient   Signature / Thumb impression  
 
Name of the investigator   Signature       Date 
 
 
